Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

NCT06756828 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Elderly
Alzheimer Disease
Melatonin
Cognitive Decline
Biomarker with Neurodegeneration Patients
Cerebellum

Interventions

DRUG: Melatonin
BEHAVIORAL: Cognitive behavioral therapy group for insomnia

Sponsor

Saint Vincent's Hospital, Korea